Cantor Fitzgerald reaffirmed their neutral rating on shares of Alphabet (NASDAQ:GOOGL – Free Report) in a report released on Wednesday,Benzinga reports. The brokerage currently has a $200.00 ...

Friday - Summit Therapeutics plc (NASDAQ:SMMT) stock received a new Overweight rating from Cantor Fitzgerald, signaling a positive outlook from the firm. The coverage initiation by Cantor Fitzgerald ...

Since ending in correction territory last week, Wall Street has rebounded, and Cantor Fitzgerald believes this rally could extend through to the end of the month. However, despite the potential ...

On Friday, Cantor Fitzgerald reaffirmed its Overweight rating and $14.00 price target for Skye Bioscience (NASDAQ:SKYE) shares. The target sits within the broader analyst range of $9.50 to $21.00 ...

In a report released today, Andres Sheppard from Cantor Fitzgerald maintained a Buy rating on Ouster (OUST – Research Report), with a price target of $11.00. The company’s shares closed ...

Alex Mastromanno discusses his plans at the FSU pro day as he looks to impress NFL scouts as a specialist. Here's what he said. Peter Holland Jr. FSU football defensive coordinator Tony White ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The judiciary is under attack; Fannie Mae just added a cybersecurity engineer at SpaceX and social media ...

Fintel reports that on March 19, 2025, Cantor Fitzgerald upgraded their outlook for Tesla (BMV:TSLA) from Neutral to Overweight. There are 2,428 funds or institutions reporting positions in Tesla.

This prediction is currently active. The prediction currently has a performance of 14.29%. This prediction currently runs until 19.03.26. The prediction end date can be changed by Cantor_Fitzgerald at ...

Cantor Fitzgerald upgraded Tesla (TSLA, Financials) to Overweight from Neutral, citing a buying opportunity following the recent sell-off, the firm announced after a site visit to Tesla's Gigafactory ...